Definitive Healthcare Corp. (NASDAQ:DH) Shares Purchased by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company grew its stake in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 17.0% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 22,896 shares of the company’s stock after purchasing an additional 3,332 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Definitive Healthcare were worth $125,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also modified their holdings of DH. Millennium Management LLC acquired a new stake in shares of Definitive Healthcare during the second quarter worth about $9,283,000. AQR Capital Management LLC purchased a new position in Definitive Healthcare during the 2nd quarter worth approximately $155,000. Cubist Systematic Strategies LLC increased its position in Definitive Healthcare by 213.8% during the second quarter. Cubist Systematic Strategies LLC now owns 219,481 shares of the company’s stock worth $1,198,000 after buying an additional 149,533 shares during the period. 272 Capital LP purchased a new stake in Definitive Healthcare in the second quarter valued at approximately $3,480,000. Finally, Marshall Wace LLP acquired a new stake in shares of Definitive Healthcare in the second quarter valued at approximately $1,535,000. Hedge funds and other institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Price Performance

Definitive Healthcare stock opened at $4.54 on Monday. The company has a market cap of $535.42 million, a P/E ratio of -2.59, a price-to-earnings-growth ratio of 6.27 and a beta of 1.33. Definitive Healthcare Corp. has a one year low of $3.19 and a one year high of $10.62. The business has a fifty day moving average of $4.36 and a two-hundred day moving average of $5.32. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.40 and a current ratio of 2.40.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings data on Monday, August 5th. The company reported $0.09 EPS for the quarter, meeting the consensus estimate of $0.09. Definitive Healthcare had a negative net margin of 156.65% and a positive return on equity of 0.98%. The firm had revenue of $63.70 million during the quarter, compared to analysts’ expectations of $63.19 million. During the same quarter last year, the business earned $0.08 earnings per share. The business’s revenue for the quarter was up 4.4% compared to the same quarter last year. As a group, analysts predict that Definitive Healthcare Corp. will post 0.07 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts recently issued reports on DH shares. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research report on Tuesday, August 6th. Barclays dropped their target price on Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 7th. Robert W. Baird decreased their price target on Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. Morgan Stanley dropped their price objective on shares of Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating on the stock in a research note on Tuesday, August 6th. Finally, Stifel Nicolaus reduced their target price on shares of Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating for the company in a research note on Wednesday, July 31st. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $5.81.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.